Atropine Administration Guidelines

Dosing and Administration

The American College of Cardiology recommends administering atropine intravenously at a dose of 0.5-1.0 mg, repeated every 3-5 minutes to a maximum total dose of 2.0-2.5 mg for bradycardia in adults 1, 2, 3
For pediatric patients, the American College of Cardiology suggests administering 0.02 mg/kg IV/IO for symptomatic bradycardia, with a minimum single dose of 0.1 mg and maximum single dose of 0.5 mg for children and 1.0 mg for adolescents 4
The American College of Cardiology advises administering atropine by slow IV push for cardiac arrest to avoid paradoxical bradycardia that may occur with doses <0.5 mg 1, 3

The American College of Cardiology recommends monitoring vital signs continuously, particularly heart rate and blood pressure, during and after administration 1, 2
The American College of Cardiology suggests observing for reversal of bradycardia within 3 minutes, which is the peak action time of intravenously administered atropine 1
For patients with acute myocardial infarction, the American College of Cardiology advises carefully observing for potential worsening of ischemia due to tachycardia following atropine administration 1, 3

The American College of Cardiology indicates that primary indications for atropine include symptomatic sinus bradycardia, type I second-degree AV block, hypotension after nitroglycerin administration, and ventricular asystole 1, 2, 3
The American College of Cardiology recommends against using atropine for type II second-degree AV block or third-degree AV block with wide-complex escape rhythm 3
For carotid stenting procedures, the American Heart Association suggests administering 0.5-1 mg prophylactically before angioplasty to prevent bradycardia 5

The American Academy of Pediatrics suggests that atropine may be excreted in milk and potentially reduce breast milk production in breastfeeding women 6

The American College of Cardiology warns that atropine may cause cardiovascular effects such as tachycardia, which could worsen ischemia in patients with acute coronary syndrome 1, 3

The American College of Cardiology recommends documenting pre-administration vital signs, indication for administration, dose given, route, time, and patient response 1, 2
The American College of Cardiology suggests recording the presence of symptoms such as hypotension, ischemic discomfort, or ventricular arrhythmias that prompted atropine administration in patients with bradycardia 2